
Genesis Therapeutics is a biotechnology and artificial intelligence (AI) company headquartered in Burlingame, California, with an integrated laboratory in San Diego. The company combines advanced generative and predictive AI models with biotechnology to discover novel small-molecule therapies for serious and treatment-resistant diseases. Genesis accelerates and optimizes drug discovery through its proprietary AI platform, GEMS (Genesis Exploration of Molecular Space).GEMS is a multilayered platf
EN
Ömer Said Aydın

Genesis Therapeutics is a biotechnology and artificial intelligence (AI) company headquartered in Burlingame, California, with a fully integrated wet laboratory in San Diego. The company combines advanced generative and predictive AI models with biotechnology to discover novel small-molecule therapeutics for severe and treatment-resistant diseases. Its proprietary GEMS (Genesis Exploration of Molecular Space) platform accelerates and optimizes drug discovery through deep learning, molecular simu
EN
Ömer Said Aydın

Genesis Therapeutics, Kaliforniya’nın Burlingame kentinde merkezi bulunan ve San Diego’da tam entegre bir laboratuvarla faaliyet gösteren bir biyoteknoloji ve yapay zekâ (YZ) şirketidir. Şirket, ileri düzey generatif ve kestirimsel yapay zekâ modelleriyle biyoteknolojiyi birleştirerek, ciddi ve tedaviye dirençli hastalıklar için yeni küçük moleküllü tedavilerin keşfine odaklanmaktadır. Genesis, bu doğrultuda geliştirdiği GEMS (Genesis Exploration of Molecular Space) adlı tescilli YZ platformuyla
TR
Ömer Said Aydın